Objective: To evaluate efficacy and safety of dendritic cells in combination with cytokine-induced killer cell treatment of patients with colorectal cancer.
Background: The proliferation and function capacity of T cells is seriously impaired in cancer patients, which results in the decrease of T cell number and
Autophagy and tumor microenvironment have both been considered to be crucial for the tumor progression.However,little is known about the potential roles of
B cells consistently represent abundant cellular components in tumors;however, direct evidence supporting a role for B cells in the immunopathogenesis of hu